Gene therapy is gaining recognition as a potential therapeutic strategy for HF, with several cardiac proteins (e.g., AC6 and SERCA2a) and β-ARKct currently being investigated as therapeutic targets [157]. The gene discussed is ADCY6; the disease is hydrops fetalis.